KRAS and lung carcinoma: In this study, it was shown that the positive KRAS gene mutation rate in exon E2 was highest in whole blood + tissue samples, patients with stage IIB, and patients with adenosquamous carcinoma; however, patients with adenocarcinoma or stage IA lung cancer were significantly more frequent than other lung cancer types or stages.